Each year in the United States, more than 15 million people undergo colonoscopy, and roughly one-quarter are surveillance procedures following removal of colon polyps. Despite how common these follow-up exams are, clinicians have long lacked strong evidence to guide one basic question: how soon is too soon for repeat colonoscopy, particularly for low-risk patients with one or two non-advanced adenomas, the most common abnormal finding.
The FORTE trial shows how large, prevention-focused studies can reshape care and how expanded support can grow clinical research across the DOM.